All In Biotech

Drug Trial Radar · NCT04248855

Assessment of KAN-101 in Celiac Disease (ACeD)

A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Patients With Celiac Disease (ACeD)

Last checked: Nov 19, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

41

Actual

Start

Jan 21, 2020

Primary completion

Oct 8, 2021

Study completion Oct 8, 2021

Sponsor

Sponsor type
Industry
First posted
Jan 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A safety study of KAN-101 in patients with celiac disease. The study has two parts: 1. Part A - first in human study in which patients receive a single dose of KAN-101 2. Part B - patients will receive three doses of either KAN-101 or placebo

Conditions

  • Celiac Disease

Interventions

  • KAN-101Drug

    Intravenous (IV) infusion

  • PlaceboDrug

    Intravenous (IV) infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and Severity of Treatment-emergent Adverse Events (TEAEs)Time frame: Up to 28 Days

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Anaheim Clinical Trials

    Anaheim, California

  • Diablo Clinical Research

    Walnut Creek, California

  • Innovative Medical Research of South Florida

    Aventura, Florida

  • GCP Research

    St. Petersburg, Florida

  • Tandem Clinical Research

    Marrero, Louisiana

  • Parexel International- EPCU Baltimore

    Baltimore, Maryland

  • West Michigan Clinical Research Center

    Wyoming, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Celiac Disease Center at Columbia University

    New York, New York

  • North Carolina Clinical Research

    Raleigh, North Carolina

  • Aventiv Research

    Columbus, Ohio

  • WR-ClinSearch, LLC

    Chattanooga, Tennessee

  • Advanced Clinical Research

    West Jordan, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.